Ichor Holdings, Ltd. designs and manufactures gas and chemical delivery subsystems and precision components used in semiconductor capital equipment, so its results serve as a real-time gauge of chip-equipment demand. The fiscal third quarter of 2026 marks a pivotal moment: after a deep downturn, revenue has now climbed roughly 50% from its recent trough in just three quarters, and profitability has returned. For investors, this report tests whether ICHR's operating-leverage story can convert accelerating wafer fab equipment (WFE) spending into durable earnings. Because the company carries heavy fixed costs, even modest volume gains flow through strongly to margins, making quarterly results a key signal on both its own execution and the health of the broader semiconductor supply chain. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter of fiscal 2026, ended September 25, 2026, Ichor reported net sales of $328.7 million, an increase of 37% year over year and 12% sequentially from $294.8 million in the prior quarter. Net sales came in slightly below the consensus estimate of about $330 million.
On the bottom line, the company reported GAAP net income of $20.9 million, a sharp reversal from a $22.9 million net loss a year earlier. Non-GAAP diluted EPS, which excludes certain one-time items, reached $0.63, well above the consensus forecast of $0.45.
Gross margin improved to 15.8%, up from 13.9% in the prior quarter, reflecting a shift toward higher-margin component sales and increased proprietary content. Operating margin also expanded materially, supported by disciplined operating expenses. The key offset was cash flow: free cash flow was negative $39.5 million, as inventory and accounts receivable grew faster than sales.
Shares of ICHR rose about 3% in early after-hours trading following the release, as investors weighed a strong profit beat against a slight revenue miss and ongoing cash burn. The market appeared to focus on the sharp margin expansion and the return to profitability, which validated the company's restructuring efforts and its shift toward higher-margin proprietary content. Sentiment also benefited from fourth-quarter guidance that points to continued sequential growth in revenue, gross margin, and EPS. However, the negative free cash flow and rising working capital remained notable concerns, reflecting the cost of a supplier scaling up to meet a steep demand ramp.
Looking ahead, Ichor guided to fourth-quarter revenue of $345 million to $365 million and non-GAAP diluted EPS of $0.65 to $0.75, implying continued sequential growth and full-year 2026 revenue growth of roughly 30%. Management has signaled that demand visibility extends well into 2027, supported by a robust WFE spending environment.
Investors should watch whether gross margin continues to climb toward the company's near-term 15% target and its longer-term 20% goal. The pace of proprietary-content adoption and the successful ramp of manufacturing-site realignment efforts will be central to sustaining that expansion.
On the other side of the ledger, cash generation remains a key watch item. Inventory and receivables have been absorbing significant cash, and management has indicated positive operating cash flow may not return until the first half of 2027. Supply-chain constraints in high-end etch and deposition segments could also temper the growth trajectory.
Finally, cost discipline and any shift in end-market demand—particularly in areas such as silicon carbide and European or lithography demand—will influence whether ICHR can keep converting revenue growth into accelerating earnings. From what I see, these elements will determine how sustainable the recovery proves to be.
In my own research process, I often turn to Tickeron’s AI Screener to quickly filter semiconductor names by fundamentals, margin trends, and recent performance. It helps surface comparable companies and highlight patterns that might otherwise take hours to identify manually. This kind of tool complements traditional earnings review by adding speed and breadth without replacing careful fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ICHR saw its Momentum Indicator move below the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 76 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 39 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
ICHR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
The 50-day moving average for ICHR moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ICHR entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for ICHR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +13.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 253 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.594) is normal, around the industry mean (6.211). P/E Ratio (-31.487) is within average values for comparable stocks, (81.436). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ICHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment
Industry ElectronicProductionEquipment